These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 18691013)

  • 1. Targeting SphK1 as a new strategy against cancer.
    Shida D; Takabe K; Kapitonov D; Milstien S; Spiegel S
    Curr Drug Targets; 2008 Aug; 9(8):662-73. PubMed ID: 18691013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sphingosine kinase 1 and tumor].
    Zhang CX; He HW; Shao RG
    Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
    Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
    Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
    Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
    Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of SphK inhibitors using crystal structures aided by computer.
    Ding T; Zhi Y; Xie W; Yao Q; Liu B
    Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
    LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
    Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine kinases signalling in carcinogenesis.
    Marfe G; Mirone G; Shukla A; Di Stefano C
    Mini Rev Med Chem; 2015; 15(4):300-14. PubMed ID: 25723458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.
    Evangelisti C; Evangelisti C; Buontempo F; Lonetti A; Orsini E; Chiarini F; Barata JT; Pyne S; Pyne NJ; Martelli AM
    Leukemia; 2016 Nov; 30(11):2142-2151. PubMed ID: 27461062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
    Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
    Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
    Lynch KR; Thorpe SB; Santos WL
    Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
    Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS
    J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Sphk1/S1P and microRNAs in human cancers.
    Khoei SG; Sadeghi H; Samadi P; Najafi R; Saidijam M
    Biotechnol Appl Biochem; 2021 Apr; 68(2):279-287. PubMed ID: 32275078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
    Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
    Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
    Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
    Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
    Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
    Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
    Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
    Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
    Maiti A; Takabe K; Hait NC
    Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and functional roles of sphingosine kinases.
    Alemany R; van Koppen CJ; Danneberg K; Ter Braak M; Meyer Zu Heringdorf D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):413-28. PubMed ID: 17242884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.
    Kohno M; Momoi M; Oo ML; Paik JH; Lee YM; Venkataraman K; Ai Y; Ristimaki AP; Fyrst H; Sano H; Rosenberg D; Saba JD; Proia RL; Hla T
    Mol Cell Biol; 2006 Oct; 26(19):7211-23. PubMed ID: 16980623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.